People in Life Sciences Series: Day-in-the-Life of a Pharmacovigilance Professional – Interview with Ashish Jain, Senior Director of Clinical Safety and PV, Curis
Listen now
Description
In this featured episode of Xtalks People in Life Sciences, Ayesha spoke with Ashish Jain, Senior Director of Clinical Safety and Pharmacovigilance (PV) at Curis, a pioneering biotech company specializing in cutting-edge cancer therapies. Jain shared his journey into clinical safety and PV, highlighting key milestones along the way. Delving into his daily routine at Curis, he revealed his strategies for prioritizing tasks and staying informed of the latest developments in PV. Throughout the interview, Jain offered invaluable insights into career advancement in clinical safety and PV. He emphasized the indispensable skills and competencies vital for success in the field. Jain also discussed common challenges faced by PV professionals and suggested practical solutions. Aspiring professionals seeking to kickstart their careers in clinical safety and PV will find Jain’s insights informative. He provides actionable recommendations for gaining hands-on experience and navigating the PV landscape. Furthermore, Jain shares his expertise in establishing a PV department, particularly for emerging biotech firms. He outlines critical considerations for setting up an efficient PV system, especially in resource-limited environments. Listeners can also hear Jain’s thoughts on emerging trends in PV and his insights on how PV professionals can proactively prepare for the future. Tune in to this episode for a glimpse into the field of clinical safety and PV with Ashish Jain. For more life science and medical device content, visit the Xtalks Vitals homepage. Follow Us on Social Media Twitter: @Xtalks Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured
More Episodes
In this episode, Ayesha spoke with Robert Barrow, CEO and Board Director at MindMed, a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders.  The company is developing innovative psychedelic-based product candidates, with and without acute...
Published 05/01/24
Published 05/01/24
In this episode, Ayesha spoke with John K. Celebi, MBA, President & Chief Executive Officer, Sensei Bio, a clinical-stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Sensei Biotherapeutics specializes in creating...
Published 04/24/24